Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

TRVITRVI
Showing 8 of 29 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in Trevi Therapeutics, Inc.

NORTHERN TRUST CORP holds 1M shares of TRVI (Trevi Therapeutics, Inc.), worth $18.8M as of 2026-Q2. The position was increased (+24.7% shares). TRVI represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$18.8M

Current Shares

1M

Total Value Change

+$17.3M

Total Shares Change

+572,396

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+24.7%
$18.8M0.0%$18.65
35
2026-Q1
Increased
806,659
+5.9%
$9.6M0.0%$12.26
29
2025-Q4
Increased
761,966
+3.4%
$9.5M0.0%$12.56
29
2025-Q3
Increased
736,930
+27.8%
$6.7M0.0%$8.95
34
2025-Q2
Increased
576,471
+1.8%
$3.2M0.0%$5.62
27
2025-Q1
Increased
566,197
+17.3%
$3.6M0.0%$6.50
31
2024-Q4
Increased
482,815
+11.3%
$2M0.0%$4.10
29
2024-Q3
Increased
433,642
+35.0%
$1.4M0.0%$3.33
33

Other major holders of TRVI: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used